Related Experiment Video

Updated: Jul 2, 2025

Fast and Specific Assessment of the Halogenating Peroxidase Activity in Leukocyte-enriched Blood Samples
05:17

Fast and Specific Assessment of the Halogenating Peroxidase Activity in Leukocyte-enriched Blood Samples

Published on: July 28, 2016

10.3K

Genetic and clinical study of myeloperoxidase's association with coronary artery disease

Lina N Adam1, Omar A M Al-Habib2, Ashur Y Oraha3

  • 1Department of Biology, College of Science, University of Zakho, Duhok, Kurdistan Region, Iraq. lina.adam@uoz.edu.krd.

The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology
|February 22, 2024
PubMed

Insights

Serum myeloperoxidase (MPO) levels show no significant difference in coronary artery disease (CAD) patients. However, mean platelet volume (MPV) and red cell distribution width (RDW%) may predict atherosclerosis severity in CAD.

Area of Science:

  • Cardiology
  • Biochemistry
  • Genetics

Background:

  • Investigating the role of myeloperoxidase (MPO) in coronary artery disease (CAD).
  • Exploring genetic variations associated with MPO and CAD.
  • Aiming to improve diagnostic accuracy and treatment for CAD.

Purpose of the Study:

  • To determine the correlation between serum MPO levels and CAD.
  • To assess the potential of MPO, MPV, and RDW% as diagnostic or prognostic markers for CAD.

Main Methods:

  • Comparative analysis of clinical parameters between CAD patients and controls.
  • Measurement of serum MPO levels.
  • Statistical analysis to identify correlations.

Main Results:

  • CAD patients were older and predominantly male.
  • Significant differences observed in glucose, bilirubin, alkaline phosphatase, creatinine, and troponin levels.
  • Lower red cell distribution width (RDW%) and mean platelet volume (MPV) in CAD patients.
  • No significant difference in serum MPO levels between CAD patients and controls.
  • MPO showed correlation only with glucose, creatinine, and total bilirubin.

Conclusions:

  • Serum MPO levels do not appear to be substantially related to CAD.
  • MPV and RDW% show potential as predictors of severe atherosclerosis in CAD.
  • Further research is required to validate the prognostic value of RDW%, MPV, and MPO in CAD.
Abstract

Keywords:
BiomarkersCardiovascular riskCoronary artery disease (CAD)Genetic variationMyeloperoxidase (MPO)

More Related Videos

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.3K
Author Spotlight: A Simple and Cost-Effective Method for Leukocyte Analysis in Semen04:36

Author Spotlight: A Simple and Cost-Effective Method for Leukocyte Analysis in Semen

Published on: January 19, 2024

4.1K

Related Concept Videos

Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
12.4K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
92